関連する実験動画

Updated: May 3, 2026

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

強化されたHsp104変種は,様々なタンパク質毒性誤折りイベントに敵対する

Meredith E Jackrel¹, Morgan E DeSantis², Bryan A Martinez³

¹Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.

|January 21, 2014

まとめ

科学者たちは酵母Hsp104を再プログラムして,ALSやパーキンソン病のような神経変性疾患に関与する有毒なタンパク質集積を溶かす強力な変種を作成しました. これらの強化された分散酵素は,プロテオスタシスを回復し,神経変性化を軽減します.

科学分野:

神経生物学神経生物学とは
分子生物学は分子生物学である.
タンパク質化学タンパク質化学

背景:

ALSやパーキンソン病のような致命的な神経変性疾患には,タンパク質の誤折り変異を逆転させる治療法がない.
酵母Hsp104分解酵素は,集積物を溶解させることができるが,ヒトの疾患タンパク質に対する有効性は限られており,メタゾアンの同類体は存在しない.

研究の目的:

ヒトの疾患に関連したタンパク質集積に対して強化された活性を持つHsp104の変種を設計する.
Hsp104変種がタンパク質毒性および神経変性抑制するメカニズムを調査する.

主な方法:

特定のドメイン (中部ドメインヘリックス1,2,または3;核酸結合ドメイン1小ドメイン) でのHsp104のサイト指向型変異.
集合体の溶解,タンパク質の局所化,細胞モデルにおけるタンパク質毒性抑制の測定.
Caenorhabditis elegans パーキンソン病のモデルで有効性をテストする.

主要な成果:

Hsp104の単一残基変異は,TDP-43,FUS,α-シヌクレインのプロテオ毒性を効果的に救済する変異を生んだ.
強化されたHsp104変種は,集積溶解を強化し,タンパク質の局所化を回復し,タンパク質毒性を抑制しました.
Hsp104の変種は,C. elegansのパーキンソン病のモデルにおけるドーパミナージック神経変異を弱めた.
変異により,Hsp104の活性が改善され,Hsp70の依存性が排除され,ATPaseとUnfoldaseの機能が強化されました.

結論:

疾患に関連したタンパク質集積は,治療可能な治療標的である.
エンジニアリングされたHsp104デサグレゲーゼは,プロテオスタシスを回復し,神経変異を軽減することができます.
Hsp104の再プログラミングは,タンパク質の誤折り症の治療に有望な戦略を提供します.

さらに関連する動画

Purification of Hsp104, a Protein Disaggregase

Purification of Hsp104, a Protein Disaggregase

Published on: September 30, 2011

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

関連する概念動画

Molecular Chaperones and Protein Folding

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...

Export of Misfolded Proteins out of the ER

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Unfolded Protein Response

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...